期刊文献+

国产奈达铂联合紫杉醇治疗晚期非小细胞肺癌 被引量:7

下载PDF
导出
出处 《中国癌症杂志》 CAS CSCD 2006年第8期679-680,共2页 China Oncology
  • 相关文献

参考文献9

  • 1Ranson MR, Jayson G, Perkins S,et al. Single-agent paclitaxel in advanced non-small-cell lung cancer: single-center phase Ⅱ study using a 3-hour administration schedule [ J ]. Semin Oncol, 1997,24(4 Suppl 12):S12-6-S12-9.
  • 2陈良良,吴良村,谢长生,舒琦瑾,周维顺.紫杉醇联合顺铂治疗Ⅲ-Ⅳ期非小细胞肺癌37例[J].实用肿瘤学杂志,2004,18(1):31-32. 被引量:13
  • 3王肇炎,王尔兵.奈达铂:一种铂类抗癌新药[J].药学进展,2002,26(4):223-226. 被引量:22
  • 4张频,冯奉仪.奈达铂[A].周际昌.实用肿瘤内科学[M].第2版,北京:人民卫生出版社,2002:397-98.
  • 5Yoshiike F,Koizumi T,Kitaguchi Y,et al. Phase I trial of nedaplatin and paclitaxel for patiens with non-small-cell lung cancer[ J ].J Chemother, 2005 Oct, 17 ( 5 ) : 550-554.
  • 6Takigawa N,Segawa Y, Ueoka H,et al. Combination of nedaplatin and vindesine for treatment of relapced or refractory non-small-cell lung cancer [ J ]. Cancer Chemother Pharmacol, 2000,46 ( 4 ) : 272-278.
  • 7Hasegawa Y, Takanashi S, Okudera K, et al. Weekly paclitaxel and nedaplatin with concurrent radiotheraphy for locally advanced nonsmall-cell lung cancer:a phase Ⅰ / Ⅱ study[J]. Jpn J Clin Oncol,2004,34( 11 ) :647-653.
  • 8徐瑞华,管忠震,姜文奇,黄河,胡晓桦,谢伟敏,李星庚,刘亚利,潘良熹,戴爱娣,庄武,张春,马智勇,王建华.奈达铂治疗非小细胞肺癌的Ⅱ期临床研究报告[J].癌症,2002,21(12):1354-1358. 被引量:132
  • 9王全助,杜京娟,石建华.奈达铂联合吉西他滨治疗晚期非小细胞肺癌[J].临床肿瘤学杂志,2004,9(6):637-638. 被引量:20

二级参考文献38

  • 1[1]Lebwohl D , Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update[J]. Eur J Cancer, 1998,34(10): 1522-1534.
  • 2[2]Muramatsu S, Ku Y, Kuroda Y. Pharmaeokinetic comparison between cisplatin and nedaplatin in hepatic arterial chemotherapy using complete hepatic venous isolation and charcoal hemoperfusion[J]. Jpn J Cancer Chemother,1998,25(9): 1457-1460.
  • 3[3]Kawanishi K, Miyagi Y, Yamamoto J, et al. Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters[J]. Cancer Chemother Pharmacol,2001,47(4): 303-308.
  • 4[4]Fujii M, Tokumaru Y, Imanishi Y, et al. Combination chemotherapy with nedaplatin and 5-FU for head neck cancer[J]. Jpn J Cancer Chemother, 1998, 25(1):53-58.
  • 5[5]Sasaoka M, Fuua N, Matsumoto A, et al. Alternating chemoradiotherapy for oropharyngeal cancer [J]. Jpm J Cancer Chemother, 2000; 27(14): 2217-2221.
  • 6[6]Takeda Y, Kasai H, Uchida N, et al. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts [J]. Anticancer Res, 1999,19 (5B): 4059-4064.
  • 7[7]Yoshioka T, Gamoh M, Shineha R, et al. A new combimation chemotherapy with cis- diammine- glycolatoplatinum (nedaplatin) and 5-fluorouracil for advanced esoiphageal cancers[J]. Intern Med, 1999, 38(11) :844-848.
  • 8[8]Hirata S, Yatsuyanagi E, Yamazaki H, et al. Neoadjuvant chemotherapy for esophageal cancer by administration of nedaplatin alone[J]. Jpm J Cancer Chemother, 2000, (2):221-226.
  • 9[9]Sumi H, Ohtsu A, Boku N, et al. A case of inoperable esophageal carcinoma with hepatic and nodal metastases which showed a long-term survival after chemradiotherapy including nedaplatin[J]. Jpn J Clin Oncol, 2000, 30(9):406-409.
  • 10[10]Matsumoto M, Takeda Y, Maki H, et al. Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer[J]. Jpn J Cancer Res, 2001, 92 (1):51-58.

共引文献167

同被引文献54

引证文献7

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部